Patrick G. Pilié
- Oncology top 2%
- PARP inhibition in cancer therapy 10
- Cancer Immunotherapy and Biomarkers 7
- Cancer Research top 5%
- Cancer Genomics and Diagnostics 8
- Cancer, Hypoxia, and Metabolism 5
- Molecular Biology top 10%
- DNA Repair Mechanisms 8
- Renal and related cancers 5
-
- Prostate Cancer Treatment and Research 15
- Renal cell carcinoma treatment 7
- Reproductive Medicine top 10%
- Co-authors
- Timothy A. YapGordon B. MillsChad TangRoss StewartLauren A. ByersMark J. O’ConnorCarl M. GayEric Jonasch
- Partner nations
- United StatesUnited KingdomChina
In The Last Decade
Patrick G. Pilié
38 papers receiving 1.8k citations
Hit Papers
Peers
Comparison fields: 5 of 82
- Oncology 1.1k
- Cancer Research 342
- Molecular Biology 1.1k
- Pulmonary and Respiratory Medicine 407
- Reproductive Medicine 91
Countries citing papers authored by Patrick G. Pilié
This map shows the geographic impact of Patrick G. Pilié's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick G. Pilié with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick G. Pilié more than expected).
Fields of papers citing papers by Patrick G. Pilié
This network shows the impact of papers produced by Patrick G. Pilié. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick G. Pilié. The network helps show where Patrick G. Pilié may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Patrick G. Pilié, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2026 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2024 | 0 | |
| 4 | 2024 | 34 | |
| 5 | 2023 | 8 | |
| 6 | 2023 | 11 | |
| 7 | 2023 | 2 | |
| 8 | 2023 | 1 | |
| 9 | 2022 | 20 | |
| 10 | 2021 | 97 | |
| 11 | 2021 | 22 | |
| 12 | 2020 | 1 | |
| 13 | 2019 | 244 | |
| 14 | 2019 | 1 | |
| 15 | 2019 | 1 | |
| 16 | 2018 | 70 | |
| 17 | State-of-the-art strategies for targeting the DNA damage response in cancerbreakdown → | 2018 | 795 |
| 18 | 2017 | 10 | |
| 19 | 2016 | 1 | |
| 20 | 2014 | 1 |
About Patrick G. Pilié
Patrick G. Pilié is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine and Oncology, having authored 43 papers that have together received 1.8k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (15 papers), PARP inhibition in cancer therapy (10 papers), DNA Repair Mechanisms (8 papers), Cancer Genomics and Diagnostics (8 papers), Renal cell carcinoma treatment (7 papers), Cancer Immunotherapy and Biomarkers (7 papers), Cancer, Hypoxia, and Metabolism (5 papers) and Renal and related cancers (5 papers). The work is most often cited by research in Oncology (1.1k citations), Cancer Research (342 citations) and Molecular Biology (1.1k citations). Patrick G. Pilié has collaborated with scholars based in United States, United Kingdom and China. Frequent co-authors include Timothy A. Yap, Gordon B. Mills, Chad Tang, Ross Stewart, Lauren A. Byers, Mark J. O’Connor, Carl M. Gay, Eric Jonasch, Daniel J. McGrail and Timothy C. Thompson. Their work appears in journals such as Nature Communications, Journal of Clinical Oncology and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.